Our Team
Kerry Lawing, CEO of Prevail, brings over 35 years of experience in building, scaling, and successfully exiting businesses. Known for his strategic vision and relentless drive, he has a proven track record of accelerating growth and creating lasting impact across multiple industries.
Before founding Prevail, Kerry established Lawing Financial in 1985, growing the company to over $5 Billion in assets under advisement before its successful sale in 2017. This pivotal transition led him to found Prevail with a mission to disrupt the age-old financial services industry by focusing on innovative wealth strategies.
His leadership continues to propel Prevail and other entities forward, fostering innovation and long-term value while dedicating himself to growing people, advisors, and businesses.
Andrew Stafford is a seasoned business leader and financial strategist with a strong background in entrepreneurship and corporate growth. Starting as a 4th generation operator of a family business, he gained firsthand experience in scaling legacy enterprises.
He’s successfully co-launched three startups and led major business units within a $750M company, driving revenue growth in two separate business units from $5M to $30M and $60M to $100M in just three years. Andrew brings a rare combination of operational expertise, scaling mastery, and deep financial acuity to Prevail’s investment thesis and portfolio support.
Timothy Bledsoe is a visionary leader with a proven track record of disrupting the healthcare landscape and scaling transformative ventures. He was an early member of Salient Surgical, acquired by Medtronic for $645 million, and led the development of a private equity-backed high-acuity surgery center business that transacted in 2022. As a Co-Founder of NextStage Clinical Research, Tim expanded access to cutting-edge trials through partnerships with top physicians in local communities.
At Prevail Venture Capital, he drives a differentiated investment strategy focused on DefenseTech, MedTech, FinTech, DeepTech, and opportunistic businesses led by compelling founders with bold vision, solving problem—leveraging curated deal access, institutional-grade diligence, and ecosystem-driven execution to accelerate growth and maximize investor returns.
Matthew Burleigh is a Charter Financial Analyst (CFA) with over 25 years of experience in buy-side investment management, focusing on sectors significantly influenced by M&A cycles.
He possesses a deep expertise in financial modeling, valuation analysis, and market forecasting. His proficiency in financial analysis enables him to assess complex investment opportunities, optimize capital allocation, and develop strategic growth plans.
Noormah has a value creation foundation, having worked a 3-year role at a specialized strategy and financial consulting firm with a strong client base in the Middle East, where she advised large national and multinational organizations. Her expertise was built by working on critical advisory functions key to corporate decision-making. These functions included thorough commercial and financial due diligence, market research and sizing to identify new opportunities, corporate strategy development for growth, and public policy guidance.
This broad experience in strategic analysis, transaction support, and market development provides the analytical depth and perspective she uses to evaluate new opportunities and founders at Prevail.
(*) Partners are key relationship consultants and are not direct partners in Prevail Venture Capital Fund I LP or any of its affiliated entities.
Contact Us Today
The information is not an offering to sell a real estate investment. The content is informative in nature and specifics are only available upon request. Investing in real estate involves risk, many times is illiquid, and use should consult your financial professionals before making any investment of this nature.
An offer or solicitation to acquire interests in the investment may only be made by our Private Placement Memorandum (“Memorandum”) in accordance with the terms of all applicable security laws. All information contained herein is subject to and qualified by the contents of the Memorandum. Participation in any securities offering is limited to Accredited investors. Please call to obtain a copy. You must read it before investing. Past performance is no guarantee of future results.
